Helga Paula1, Barbara Tribl2, Elisabeth Presterl3, Magda Diab-El Schahawi1. 1. Department of Hospital Hygiene and Infection Control, Vienna General Hospital, Medical University of Vienna, Vienna, Austria. 2. Department of Medicine III, Division of Gastroenterology and Hepatology, Vienna General Hospital, Medical University of Vienna, Vienna, Austria. 3. Department of Hospital Hygiene and Infection Control, Vienna General Hospital, Medical University of Vienna, Vienna, Austria. Electronic address: elisabeth.presterl@meduniwien.ac.at.
Abstract
BACKGROUND: Endoscopes are well-known sources of bacterial transmission in health care facilities offering endoscopy services. The association between multidrug-resistant bacterial infections in patients who had undergone an endoscopic retrograde cholangiopancreatography procedure with reprocessed duodenoscopes has been much discussed. Bacterial contamination of duodenoscopes has been attributed to difficulties with reprocessing these devices, specifically the distal end of the scope, which features a movable forceps elevator. In light of a recent Food and Drug Administration warning letter to Olympus regarding their closed-channel duodenoscope model TJF-Q180V, the aim of our study was to prospectively evaluate the efficacy and safety of our current reprocessing procedures with regard to the TJF-Q180V duodenoscope models used in our hospital. METHODS: From August 2015-March 2016, we prospectively collected microbiologic surveillance samples from 6 TJF-Q180V model duodenoscopes in routine use at the Division of Gastroenterology and Hepatology using the ESwab collection system (COPAN Diagnostics Inc, Murrieta, CA). RESULTS: A total of 237 microbiologic samples from the forceps elevator were obtained during the survey period. None of the samples yielded microorganism growth. CONCLUSION: These findings suggest that when following a diligent and validated reprocessing standard in accordance with manufacturer's recommendations, closed-channel endoscope models can still be used. Nevertheless, validated adaptions of current closed-channel duodenoscope models are needed to allow for simple and safe reprocessing. Furthermore, comprehensive postmarket surveillance needs to be established.
BACKGROUND: Endoscopes are well-known sources of bacterial transmission in health care facilities offering endoscopy services. The association between multidrug-resistant bacterial infections in patients who had undergone an endoscopic retrograde cholangiopancreatography procedure with reprocessed duodenoscopes has been much discussed. Bacterial contamination of duodenoscopes has been attributed to difficulties with reprocessing these devices, specifically the distal end of the scope, which features a movable forceps elevator. In light of a recent Food and Drug Administration warning letter to Olympus regarding their closed-channel duodenoscope model TJF-Q180V, the aim of our study was to prospectively evaluate the efficacy and safety of our current reprocessing procedures with regard to the TJF-Q180V duodenoscope models used in our hospital. METHODS: From August 2015-March 2016, we prospectively collected microbiologic surveillance samples from 6 TJF-Q180V model duodenoscopes in routine use at the Division of Gastroenterology and Hepatology using the ESwab collection system (COPAN Diagnostics Inc, Murrieta, CA). RESULTS: A total of 237 microbiologic samples from the forceps elevator were obtained during the survey period. None of the samples yielded microorganism growth. CONCLUSION: These findings suggest that when following a diligent and validated reprocessing standard in accordance with manufacturer's recommendations, closed-channel endoscope models can still be used. Nevertheless, validated adaptions of current closed-channel duodenoscope models are needed to allow for simple and safe reprocessing. Furthermore, comprehensive postmarket surveillance needs to be established.
Authors: Michelle J Alfa; Harminder Singh; Zoann Nugent; Donald Duerksen; Gale Schultz; Carol Reidy; Patricia DeGagne; Nancy Olson Journal: Front Med (Lausanne) Date: 2017-11-07
Authors: Travis J De Wolfe; Nasia Safdar; Megan Meller; John Marx; Patrick R Pfau; Eric M Nelsen; Mark E Benson; Anurag Soni; Mark Reichelderfer; Megan Duster; Deepak V Gopal Journal: Can J Gastroenterol Hepatol Date: 2019-11-18
Authors: Valentina Marchese; Daniele Di Carlo; Gaetano Fazio; Santi Mauro Gioè; Angelo Luca; Rossella Alduino; Monica Rizzo; Fabio Tuzzolino; Francesco Monaco; Pier Giulio Conaldi; Bruno Douradinha; Giuseppina Di Martino Journal: Int J Environ Res Public Health Date: 2021-03-16 Impact factor: 3.390